Insider · CIK 0001826967

Vitorovic Stefan

Reports to the SEC for 3 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001826967

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,200
2025-08-05	Vigil Neuroscience, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.1K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.2K sh	—	—	0
2025-06-09	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,200
2025-05-22	Vigil Neuroscience, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2024-06-20	TECXTectonic Therapeutic, Inc.A Award	Director	AAward	+1M sh	—	—	1,000,900
2024-06-20	TECXTectonic Therapeutic, Inc.A Award	Director	AAward	+27.8K sh	—	—	27,774
2024-06-20	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.8K sh	—	—	11,760
2024-06-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+18.1K sh	—	—	18,068
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.2K sh	—	—	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,155
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+13.9K sh	—	—	13,928
2023-06-07	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director	AAward	+13.9K sh	—	—	13,928
2022-06-09	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,155
2022-05-26	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.8K sh	—	—	22,753
2022-01-11	Vigil Neuroscience, Inc.C Conversion	Director	CConversion	+3.33M sh	—	—	3,333,245
2022-01-11	Vigil Neuroscience, Inc.C Conversion	Director	CConversion	+7,684 sh	—	—	7,684
2022-01-11	Vigil Neuroscience, Inc.P Purchase	Director	PPurchase	+1.67M sh	$14.00	+$23.4M	5,004,393
2022-01-11	Vigil Neuroscience, Inc.P Purchase	Director	PPurchase	+3,852 sh	$14.00	+$53.9K	11,536
2022-01-11	Vigil Neuroscience, Inc.Series B Preferred StockC Conversion	Director	CConversion	−9.24M sh	—	—	0
2022-01-11	Vigil Neuroscience, Inc.Series B Preferred StockC Conversion	Director	CConversion	−21.3K sh	—	—	0
2021-06-08	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.3K sh	—	—	22,343
2020-10-20	PRAXPraxis Precision Medicines, Inc.C Conversion	Director	CConversion	+2.69M sh	—	—	2,689,329
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−4.15M sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series B -1 Preferred StockC Conversion	Director	CConversion	−552K sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−171K sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series C -1 Preferred StockC Conversion	Director	CConversion	−882K sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc.C Conversion	Director	CConversion	+2.69M sh	—	—	2,689,329
2020-10-20	PRAXPraxis Precision Medicines, Inc.P Purchase	Director	PPurchase	+250K sh	$19.00	+$4.75M	2,939,329
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−4.15M sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series B-1 Preferred StockC Conversion	Director	CConversion	−552K sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−171K sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series C-1 Preferred StockC Conversion	Director	CConversion	−882K sh	—	—	0

Recent filings

Accepted (ET)
Jun 104
Vitorovic Stefan0001826967-26-000003
SEC(opens sec.gov)
Aug 54
Vitorovic Stefan0000950170-25-102491
SEC(opens sec.gov)
Jun 114
Vitorovic Stefan0001415889-25-016675
SEC(opens sec.gov)
May 234
Vitorovic Stefan0000950170-25-077276
SEC(opens sec.gov)
Jun 244
Vitorovic Stefan0001415889-24-017995
SEC(opens sec.gov)
Jun 74
Vitorovic Stefan0000950170-24-070843
SEC(opens sec.gov)
May 74
Vitorovic Stefan0000950170-24-054700
SEC(opens sec.gov)
Jun 94
Vitorovic Stefan0000899243-23-015163
SEC(opens sec.gov)
Jun 134
Vitorovic Stefan0000899243-22-022159
SEC(opens sec.gov)
May 274
Vitorovic Stefan0001689548-22-000067
SEC(opens sec.gov)
Jan 114
Vitorovic Stefan0000899243-22-001650
SEC(opens sec.gov)

Companies

Address

C/O TECTONIC THERAPEUTIC, INC. 490 ARSENAL WAY, SUITE 200

WATERTOWN, MA, 02472